Within this second volume dealing with breast
and bladder cancer, the editors and authors will detail the latest research
related to the application of AI to cancer diagnosis and prognosis and
summarize its advantages. It’s the editors and authors intention to explore how
AI assists in these activities, specifically with regard to its unprecedented
accuracy, which is even higher than that of general statistical applications in
oncology. Ways will also be demonstrated as to how these methods in AI are advancing
the field.
There have been thousands of papers written between 1995 and 2019 related to AI for cancer diagnosis and prognosis. However, to this date (and unknown to the Editors) there has not yet been published a comprehensive overview of the latest findings pertaining to these AI technologies, with a single book project(s). Therefore, the purpose of this three volume work and particularly for this second volume dealing with breast and bladder cancer, is to present a compendium of these findings related to these two pervasive cancers. Many of the chapter authors are world class researchers in these technologies. Within this coverage it’s our hope that scientists, researchers and clinicians can successfully incorporate these techniques into other significant cancers such as pancreatic, esophageal, leukemia, melanoma, etc.
Sobre o autor
Ayman El-Baz, Ph.D, is Professor, Chair of the Bioengineering Department and Distinguished Scholar, Speed School of Engineering, University of Louisville, USA. His major research focus is in the fields of bioimaging modalities and computer-assisted diagnostic systems. He has developed new techniques for analyzing 3D medical images. Dr. El-Baz has authored or co-authored more than 300 technical articles and edited or co-edited over 45 books. Among his many honors and awards are becoming an AIMBE Fellow (2018) and NAI Fellow (2020)Jasjit S. Suri, Ph.D. is an innovator, scientist and industrialist, who has conducted considerable research in the implementation of AI in biomedicine and healthcare. He has over 50 US and European patents. Dr. Suri has published over 100 journal articles related to cardiovascular disease and another 100 dealing with AI. He has also edited or co-edited over 50 books. In 2018 he was awarded the Marquis Life Time Achievement Award and the Director General’s President’s Gold Medial. In addition he is an AIMBE Fellow and IEEE Fellow.